$168.71
-5.37-3.08%
Last update: Nov 10, 4:37 AM
Palvella Therapeutics Inc
PVLANASDAQ
The average analyst price target for Palvella Therapeutics is $173.42, 0.2% below the current price. Of 17 analysts, 17 rate it Buy. Targets range from $38 to $250. The latest change came on Nov 9, 2026, when Canaccord Genuity raised its price target on Palvella Therapeutics from $232 to $243 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months
